NaV1.7 as a pain target – From gene to pharmacology
Irina Vetter(Centre National de la Recherche Scientifique), Mehdi Mobli(The University of Queensland), Alexander Mueller(Princeton University), Hana Starobova(The University of Queensland), Jennifer R. Deuis(The University of Queensland), Lachlan D. Rash(The University of Queensland), Alan Zhang(The University of Queensland), Mathilde R. Israel(King's College London)
Cited by 125
Related Papers
A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases
|Nature Medicine|2015|2.8k
Methods Used to Evaluate Pain Behaviors in Rodents
|Frontiers in Molecular Neuroscience|2017|1.3k
Pathophysiology of Chemotherapy-Induced Peripheral Neuropathy
|Frontiers in Molecular Neuroscience|2017|654
Conus Venom Peptide Pharmacology
|Pharmacological Reviews|2012|422